Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance
M. Colombo(Human Technopole), Raffaella Chiaramonte(University of Milan), Marzia Barbieri(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), L. Apicella, R. Colella(University of Milan), S. Garavelli(University of Milan), Antonino Neri(University of Milan), Anna Pistocchi(University of Milan), Andrea Basile(University of Milan), M. Lancellotti(University of Milan), Domenica Giannandrea(University of Milan), Elena Lesma(Ospedale San Paolo), Mara Mazzola(University of Milan), Elisa Taìana(University of Milan), Elisa Lazzari(University of Trieste), Maria Teresa Palano(University of Milan), Mauro Turrini(Ospedale Valduce), Natalia Platonova(University of Milan), Silvia Ancona(University of Milan)
Cited by 27
Related Papers
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
|Leukemia|2009|877
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
|The Lancet Haematology|2020|553
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
|Blood|2015|216
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma
|Nature Communications|2017|142